
NIH-Funded Breakthrough Shrinks CRISPR for Precision In-Vivo Delivery
An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enabling precise in-vivo gene editing...
Read Full Story →Explore our comprehensive coverage of healthcare innovation, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

An NIH-funded research team has engineered a significantly smaller and more stable CRISPR enzyme, Al3Cas12f RKK, enabling precise in-vivo gene editing...
Read Full Story →
HealthResearchers have validated a highly accurate blood test for Alzheimer's disease that achieves 88% to...
HealthA novel blood test for Alzheimer’s disease has achieved up to 90% accuracy in clinical trials, mat...
BusinessThe p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accu...
Medical ResearchThe p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accu...
HealthcareThe FDA has cleared the LactatePatch Pro, a continuous wearable biosensor for interstitial lactate m...
HealthcareThe FDA has granted De Novo clearance to FocusFlow, a prescription digital therapeutic for pediatric...